Burlingame, California
United States
6
2024-09-05
5
2025-04-01
These are the the leading inventors for applications assigned to Attralus, Inc.:
Attralus, Inc. based in Burlingame, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Modified immunoglobulins for targeting amyloid deposits
#2 | 2024-09-05 ✅ Patent 12,157,765 granted on 2024-12-03Modified immunoglobulins for targeting amyloid deposits
#3 | 2024-07-04PEPTIDE-FC FUSIONS FOR TREATING AMYLOID DISORDERS
#4 | 2023-12-28 ✅ Patent 12,139,529 granted on 2024-11-12Antibody-peptide fusion proteins for treating amyloid disorders
#5 | 2023-08-24 ✅ Patent 12,030,934 granted on 2024-07-09Modified immunoglobulins for targeting amyloid deposits
#6 | 2022-05-26 ✅ Patent 12,161,692 granted on 2024-12-10SAP FC fusion proteins and methods of use
Also check out Attralus, Inc.'s (Burlingame, United States) applicant profile with 4 patent applications submitted.
619021 ⎘